Literature DB >> 11154993

Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies.

T Takubo1, T Kumura, T Nakao, H Nakamae, Y Aoyama, S Nishiki, Y Kinoshita, K R Koh, K Ohta, T Yamane, M Hino, T Kamitani, N Tatsumi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154993     DOI: 10.1159/000039750

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  4 in total

1.  Preparation and identification of scFv and bsFv against transferrin receptor.

Authors:  Jing Liu; Daiwen Xiao; Xiaoou Zhou; Xue Wen; Hong Dai; Zhihua Wang; Xin Shen; Wei Dai; Daofeng Yang; Guanxin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

Review 2.  New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia.

Authors:  Małgorzata Banaszkiewicz; Jolanta Małyszko; David H Vesole; Karolina Woziwodzka; Artur Jurczyszyn; Marcin Żórawski; Marcin Krzanowski; Jacek Małyszko; Krzysztof Batko; Marek Kuźniewski; Katarzyna Krzanowska
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

3.  Generation and functional characterization of the anti-transferrin receptor single-chain antibody-GAL4 (TfRscFv-GAL4) fusion protein.

Authors:  Qing Ye; Heyu Hu; Zhihua Wang; Tong Lu; Zhiquan Hu; Xing Zeng; Shu Zhang; Jing Liu; Ping Lei; Cong-Yi Wang; Zhangqun Ye; Guanxin Shen
Journal:  BMC Biotechnol       Date:  2012-11-28       Impact factor: 2.563

4.  The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment.

Authors:  Małgorzata Banaszkiewicz; Jolanta Małyszko; Krzysztof Batko; Ewa Koc-Żórawska; Marcin Żórawski; Paulina Dumnicka; Artur Jurczyszyn; Karolina Woziwodzka; Aleksandra Maleszka; Marcin Krzanowski; Andrzej Kraśniak; Ryszard Drożdż; Katarzyna Krzanowska
Journal:  Medicina (Kaunas)       Date:  2022-03-11       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.